View prices & discounts
Free gifts
Request & accept offers online
Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HHV-4 recombinant p18 antigen Region: 1-119aa | Login | HHV-4 recombinant p18 antigen Region: 1-119aa | ||||||||||||||||
|
||||||||||||||||||
| HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. | Login | HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. | ||||||||||||||||
|
||||||||||||||||||
| HIV-2 gp32 recombinant antigen. | Login | HIV-2 gp32 recombinant antigen. | ||||||||||||||||
|
||||||||||||||||||
| HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. | Login | HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. | ||||||||||||||||
|
||||||||||||||||||
| HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa | Login | HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa | ||||||||||||||||
|
||||||||||||||||||
| T. Pallidum recombinant antigen p15 (full length) | Login | T. Pallidum recombinant antigen p15 (full length) | ||||||||||||||||
|
||||||||||||||||||
| T. Pallidum recombinant antigen p45 (full length) | Login | T. Pallidum recombinant antigen p45 (full length) | ||||||||||||||||
|
||||||||||||||||||
| Zika Virus NS1 antigen 34 kDa | Login | Zika Virus NS1 antigen 34 kDa | ||||||||||||||||
|
||||||||||||||||||
| anti-Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus | Login | anti-Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus | ||||||||||||||||
|
||||||||||||||||||
| anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. | Login | anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. | ||||||||||||||||
|
||||||||||||||||||
| anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | Login | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | ||||||||||||||||
|
||||||||||||||||||
| anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | Login | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | ||||||||||||||||
|
||||||||||||||||||
| anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | Login | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | ||||||||||||||||
|
||||||||||||||||||
| anti-FAS IgM (monoclonal) | Login | anti-FAS IgM (monoclonal) | ||||||||||||||||
|
||||||||||||||||||
| anti-CD20 monoclonal antibody | Login | anti-CD20 monoclonal antibody | ||||||||||||||||
|
||||||||||||||||||
| anti-CD45 RA IgG2 monoclonal antibody | Login | anti-CD45 RA IgG2 monoclonal antibody | ||||||||||||||||
|
||||||||||||||||||
| anti-CD54 IgG2b-k monoclonal antibody | Login | anti-CD54 IgG2b-k monoclonal antibody | ||||||||||||||||
|
||||||||||||||||||
| anti-CD66e IgG1 monoclonal antibody | Login | anti-CD66e IgG1 monoclonal antibody | ||||||||||||||||
|
||||||||||||||||||
| anti-CD20 B-lymphocytes | Login | anti-CD20 B-lymphocytes | ||||||||||||||||
|
||||||||||||||||||
| anti-CD25 IL-2 receptor expressed on activated T and B cells | Login | anti-CD25 IL-2 receptor expressed on activated T and B cells | ||||||||||||||||
|
||||||||||||||||||
| anti-CD45 Leukocytes | Login | anti-CD45 Leukocytes | ||||||||||||||||
|
||||||||||||||||||
| anti-CD45 RA B-cells, T-cells, NK-cells | Login | anti-CD45 RA B-cells, T-cells, NK-cells | ||||||||||||||||
|
||||||||||||||||||
| anti-Transferrin receptor on activated T-B-, cells | Login | anti-Transferrin receptor on activated T-B-, cells | ||||||||||||||||
|
||||||||||||||||||
| anti-FAS antigen | Login | anti-FAS antigen | ||||||||||||||||
|
||||||||||||||||||
| anti-HLA-DR | Login | anti-HLA-DR | ||||||||||||||||
|
||||||||||||||||||
Contact
Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
50823 Cologne
Germany
T +49 221 126 02 66
F +49 221 126 02 67
